Guardant Health CFO exercises RSUs, 6,869 shares withheld
Guardant Health, Inc. Chief Financial Officer Michael Brian Bell exercised restricted stock units into common shares and had shares withheld for taxes.
Rhea-AI Filing Summary
Guardant Health, Inc. Chief Financial Officer Michael Brian Bell exercised restricted stock units into common shares and had shares withheld for taxes. On April 1, 2026, he converted multiple restricted stock unit awards into a total of 12,777 shares of common stock at a conversion price of $0.00 per share.
In a related tax-withholding transaction, 6,869 common shares were retained by the company at $91.15 per share to satisfy tax liabilities tied to the RSU vesting. After these transactions, Bell directly held 49,509 shares of Guardant Health common stock, reflecting routine equity compensation activity rather than an open-market trade.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Restricted Stock Units | 2,084 | $0.00 | $0.00 |
| Exercise | Restricted Stock Units | 3,324 | $0.00 | $0.00 |
| Exercise | Restricted Stock Units | 7,369 | $0.00 | $0.00 |
| Exercise | Common Stock | 2,084 | $0.00 | $0.00 |
| Exercise | Common Stock | 3,324 | $0.00 | $0.00 |
| Exercise | Common Stock | 7,369 | $0.00 | $0.00 |
| Exercise Price or Tax Liability | Common Stock | 6,869 | $91.15 | $626K |
Footnotes (5)
- F1. These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability.
- F2. This represents a restricted stock unit award granted on December 13, 2023 that vests over a three-year period. 33% of the shares subject to such award vested on October 1, 2024 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter.
- F3. Not applicable for Restricted Stock Units.
- F4. This represents a restricted stock unit award granted on November 8, 2024 that vests over a three-year period. 33% of the shares subject to such award vested on October 1, 2025 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter.
- F5. This represents a restricted stock unit award granted on March 12, 2025 that vests over a three-year period. 33% of the shares subject to such award vested on April 1, 2026 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter.
Key Figures
Key Terms
Restricted Stock Units financial
tax withholding obligations financial
vests over a three-year period financial
equal quarterly installments financial
tax-withholding disposition financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Guardant Health (GH) CFO Michael Brian Bell report in this Form 4?
Are the Guardant Health (GH) CFO’s reported transactions open-market buys or sells?
What are the vesting terms of the CFO’s restricted stock unit awards at Guardant Health (GH)?
AI-generated analysis. How Rhea-AI works. Not financial advice.